Old Web
English
Sign In
Acemap
>
authorDetail
>
Razvan-Ovidiu D. Curca
Razvan-Ovidiu D. Curca
Medicine
FOLFIRI
Colorectal cancer
Aflibercept
Biomarker (medicine)
3
Papers
52
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Assessing the impact of antiemetic guideline compliance on prevention of chemotherapy-induced nausea and vomiting (CINV): Results of the Nausea/Emesis Registry in Oncology (NERO).
2020
Journal of Clinical Oncology
Matti Aapro
Marika Chrápavá
Razvan-Ovidiu D. Curca
Laurentia Gales
Alexandru Calim Grigorescu
Bára Karlínová
Renata Kellnerová
Edgar Petru
Adam Pluzanski
Maryna Rubach
Guenther G. Steger
P. Tesarova
Nicolay Yordanov
Anna Walaszkowska-Czyż
Show All
Source
Cite
Save
Citations (1)
Velour trial biomarkers update: Impact of RAS, BRAF, and sidedness on aflibercept activity.
2017
Journal of Clinical Oncology
Pratyaksha Wirapati
Valentina Pomella
Ben Vandenbosch
Peter Kerr
Evaristo Maiello
Grahame Mark Jeffery
Razvan-Ovidiu D. Curca
Meinolf Karthaus
John Bridgewater
Anca C. Mihailov
Igor Kiss
Sandra Merino
Joseph McKendrick
Zacharenia Saridaki
Xavier Sagaert
Sabine Tejpar
Show All
Source
Cite
Save
Citations (30)
Velour trial biomarkers update: Impact of RAS, BRAF, and sidedness on aflibercept activity.
2017
Journal of Clinical Oncology
Pratyaksha Wirapati
Valentina Pomella
Ben Vandenbosch
Peter Kerr
Evaristo Maiello
Grahame Mark Jeffery
Razvan-Ovidiu D. Curca
Meinolf Karthaus
John Bridgewater
Anca C. Mihailov
Igor Kiss
Sandra Meriño
Joseph McKendrick
Zacharenia Saridaki
Xavier Sagaert
Sabine Tejpar
Show All
Source
Cite
Save
Citations (21)
1